Industry discussion often goes straight to ‘what does good look like’ when it comes to the level of design detail that needs to be submitted to the Building Safety Regulator to demonstrate that a ...

Having the correct materials for the formulation and manufacture of drug products is crucial. But what happens if a supplier can no longer provide the needed product? Changing a supplier ...

Change of lot or extension of reference standard shelf-life is considered low risk and should be downgraded from prior-approval to being managed in the Pharmaceutical Quality System (PQS) only based ...

Geoff Wilkinson Can you explain the new duty holder roles? Colin Blatchford Brown New duty holder roles will be introduced through revisions to building regulations and will apply to all buildings, ...

This professional feature discusses fees, design and build, and the benefits of RIBA’s Principal Designer Register for medium-sized architecture practices. The second in our short series of articles ...

Despite their frequent interchangeable use, understanding the distinction between validation and qualification is critical in pharmaceutical environments. Validation is a broader concept encompassing ...